Louise Glover

Affiliation(s):
Trinity College Dublin; Merrion Fertility Clinic; University College Dublin 

Department:
Reproductive Medicine (Fertility)

Research interests:
Reproductive Immunology; Assisted Reproduction; Endometriosis; Fertility Preservation

PubMed Profile
https://www.ncbi.nlm.nih.gov/myncbi/14IToso21JLQ4/bibliography/public/

ORCID Profile
https://orcid.org/0000-0001-9056-1810

Biography

Dr Louise Glover is Head of Research at Merrion Fertility Clinic on the National Maternity Hospital campus. She also holds adjunct positions (Assistant Professor/Clinical Lecturer) at both TCD and UCD Schools of Medicine. Dr Glover completed her postdoctoral training in Massachusetts General Hospital and Harvard Medical School in Boston M.A., and was appointed Assistant Professor of Medicine at the University of Colorado, where she worked in the field of mucosal immunology. She has previously served in the role of Principle Investigator and Co-investigator on projects funded by the U.S. National Institutes of Health (NIH) and Veterans Affairs. Dr Glover supervises a team of clinical (MD) and scientific (PhD, MSc) researchers investigating subfertility and its underlying mechanisms. Our translational research group maintains an active and productive portfolio, aimed at improving knowledge, expertise and care pathways in the field of reproductive medicine and assisted human reproduction (AHR), Dr Glover holds active memberships to the European Society of Human Reproduction and Embryology (ESHRE) and the British Fertility Society and is a member of the BFS Special Interest Group for Fertility Preservation. Her primary research interests are fertility preservation in adolescents and young adults facing gonadotoxic treatment, and reproductive immunology, in particular how ovarian and endometrial immune pathways are altered in subfertility.

Publications

1. Fee N, Joyce N, Horan M, Glover L, Crosby D. Outcomes of adolescents and young adults (AYA) attending for fertility counselling and oocyte cryopreservation prior to gonadotoxic treatment. J Assist Reprod Genet. 2026 Jul;43(7):2035-2043. doi: 10.1007/s10815-026-03889-z. Epub 2026 May 2. PMID: 42068486; PMCID: PMC13518653.
   
   
2. Giangrazi F, Sugrue JA, Sularea VM, Brugman AAI, Horan M, Wingfield M, Crosby DA, Glover LE, O'Farrelly C. Contribution of endometrial microbiome to inflammation-mediated infertility in women undergoing ART. Hum Reprod. 2026 Mar 1;41(3):394-409. doi: 10.1093/humrep/deaf252. PMID: 41633818; PMCID: PMC13017832.
   
   
3. Browning J, Ghanim M, Jagoe W, Cullinane J, Glover LE, Wingfield M, Kelly VP. Membrane-bound receptor for advanced glycation end products (RAGE) is a stable biomarker of low-quality sperm. Hum Reprod Open. 2024 Nov 7;2024(4):hoae064. doi: 10.1093/hropen/hoae064. PMID: 39553285; PMCID: PMC11568349.
   
   
4. Crosby DA, Glover LE, Brennan EP, Kelly P, Cormican P, Moran B, Giangrazi F, Downey P, Mooney EE, Loftus BJ, McAuliffe FM, Wingfield M, O'Farrelly C, Brennan DJ. Dysregulation of the interleukin-17A pathway in endometrial tissue from women with unexplained infertility affects pregnancy outcome following assisted reproductive treatment. Hum Reprod. 2020 Aug 1;35(8):1875-1888. doi: 10.1093/humrep/deaa111. PMID: 32614049; PMCID: PMC7775620.
   
   
5. Glover LE, Crosby D, Thiruchelvam U, Harmon C, Chorcora CN, Wingfield MB, O'Farrelly C. Uterine natural killer cell progenitor populations predict successful implantation in women with endometriosis-associated infertility. Am J Reprod Immunol. 2018 Mar;79(3). doi: 10.1111/aji.12817. Epub 2018 Jan 30. PMID: 29380456.